Top Banner
Figure E S M 1a.Δ V olum eA o vs.S troke D istanceA o: T ransonics F low Probe vs.D eltex E D M Dog 4/20- Baseline IVC Occlusion and Altered S tates 5.00 6.00 7.00 8.00 9.00 10.00 11.00 12.00 13.00 14.00 15.00 5.00 7.00 9.00 11.00 13.00 15.00 17.00 19.00 21.00 23.00 25.00 T ran so nics Flow P robe (m l) D eltex ED M (cm) Baseline P re N orepinephrine N orepinephrine P re N ipride N ipride P re D obutamine Dobutam ine AFP vs. EDM Baseline y = 1.1167x - 5.1519 R 2 = 0.9415 Pre Norepinephrine y = 0.7995x + 0.5933 R 2 = 0.6236 Norepinephrine y = 0.5369x + 1.1482 R 2 = 0.8694 Pre Nipride y = 0.5741x + 2.1024 R 2 = 0.962 Nipride y = 0.7009x + 0.6051 R 2 = 0.9405 Pre Dobutamine y = 0.8836x - 2.4988 R 2 = 0.93 Dobutamine
18

AFP vs. EDM Baseline y = 1.1167x - 5.1519 R 2 = 0.9415 Pre Norepinephrine y = 0.7995x + 0.5933

Jan 03, 2016

Download

Documents

tanisha-wood

AFP vs. EDM Baseline y = 1.1167x - 5.1519 R 2 = 0.9415 Pre Norepinephrine y = 0.7995x + 0.5933 R 2 = 0.6236 Norepinephrine y = 0.5369x + 1.1482 R 2 = 0.8694 Pre Nipride y = 0.5741x + 2.1024 R 2 = 0.962 Nipride y = 0.7009x + 0.6051 R 2 = 0.9405 Pre Dobutamine - PowerPoint PPT Presentation
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: AFP vs. EDM Baseline y = 1.1167x - 5.1519 R 2  = 0.9415 Pre Norepinephrine y = 0.7995x + 0.5933

Figure ESM 1a. ΔVolumeAo vs. Stroke DistanceAo: Transonics Flow Probe vs. Deltex EDM

Dog 4/20- Baseline IVC Occlusion and Altered States

5.00

6.00

7.00

8.00

9.00

10.00

11.00

12.00

13.00

14.00

15.00

5.00 7.00 9.00 11.00 13.00 15.00 17.00 19.00 21.00 23.00 25.00

Transonics Flow Probe (ml)

De

lte

x E

DM

(c

m)

Baseline

Pre Norepinephrine

Norepinephrine

Pre Nipride

Nipride

Pre Dobutamine

Dobutamine

AFP vs. EDM

Baseline

y = 1.1167x - 5.1519

R2 = 0.9415

Pre Norepinephrine

y = 0.7995x + 0.5933

R2 = 0.6236

Norepinephrine

y = 0.5369x + 1.1482

R2 = 0.8694

Pre Nipride

y = 0.5741x + 2.1024

R2 = 0.962

Nipride

y = 0.7009x + 0.6051

R2 = 0.9405

Pre Dobutamine

y = 0.8836x - 2.4988

R2 = 0.93

Dobutamine

y = 0.9327x - 7.7759

R2 = 0.9702

Page 2: AFP vs. EDM Baseline y = 1.1167x - 5.1519 R 2  = 0.9415 Pre Norepinephrine y = 0.7995x + 0.5933

Figure ESM 1b. Bland-Altman Analysis:

Transonics Flow Probe vs. Deltex EDM Dog 4/20- Baseline IVC Occlusion and Altered States

-10.00

-8.00

-6.00

-4.00

-2.00

0.00

5 7 9 11 13 15 17 19

(Deltex EDM+Transonics Flow Probe)/2

(De

lte

x E

DM

-Tra

ns

on

ics

Flo

w P

rob

e)

Baseline

Norepinephrine

Pre Nipride

Nipride

Pre Dobutamine

Dobutamine

Page 3: AFP vs. EDM Baseline y = 1.1167x - 5.1519 R 2  = 0.9415 Pre Norepinephrine y = 0.7995x + 0.5933

Figure ESM 2a. ΔVolumeLV vs. Stroke DistanceAO: Conductance Catheter vs. Deltex EDM

Dog 5/17- Baseline IVC Occlusion and Altered States

10.00

12.00

14.00

16.00

18.00

20.00

22.00

24.00

26.00

28.00

0.00 5.00 10.00 15.00 20.00 25.00 30.00 35.00

Conductance Catheter (ml)

De

lte

x E

DM

(c

m)

Baseline

Pre Norepinephrine

Norepinephrine

Pre Nipride

Nipride

Pre Dobutamine

Dobutamine

CC vs. Deltex

Baseline

y = 1.5803x + 4.9921

R2 = 0.8907

Pre Norepinephrine

y = 0.9411x + 9.7971

R2 = 0.894

Norepinephrine

y = 0.8756x + 9.5455

R2 = 0.8849

Pre Nipride

y = 0.2731x + 16.589

R2 = 0.5655

Nipride

y = 0.8815x + 13.854

R2 = 0.8589

Pre Dobutamine

y = 0.302x + 15.776

R2 = 0.8693

Dobutamine

y = 0.3617x + 19.09

R2 = 0.9124

Page 4: AFP vs. EDM Baseline y = 1.1167x - 5.1519 R 2  = 0.9415 Pre Norepinephrine y = 0.7995x + 0.5933

Figure ESM 2b. Bland-Altman Analysis:

Conductance Catheter vs. Deltex EDMDog 5/17- Baseline IVC Occlusion and Altered States

-10.00

-5.00

0.00

5.00

10.00

15.00

0 5 10 15 20 25 30 35

(De ltex EDM +Conductance Catheter)/2

(De

lte

x E

DM

-Co

nd

uc

tan

ce

Ca

the

ter)

Baseline

Pre Norepinephrine

Norepinephrine

Pre Nipride

Nipride

Pre Dobutamine

Dobutamine

Page 5: AFP vs. EDM Baseline y = 1.1167x - 5.1519 R 2  = 0.9415 Pre Norepinephrine y = 0.7995x + 0.5933

Figure ESM 2c. Conductance Catheter vs. PiCCO Dog 5/17- Baseline IVC Occlusion and Altered States

10.00

12.00

14.00

16.00

18.00

20.00

22.00

24.00

0.00 5.00 10.00 15.00 20.00 25.00 30.00 35.00

Conductance Catheter (ml)

PiC

CO

(m

l)

Baseline

Pre Norepinephrine

Norepinephrine

Pre Nipride

Nipride

Pre Dobutamine

Dobutamine

AFP vs. PCCO

Baseline

y = 0.4669x + 13.619

R2 = 0.7998

Pre Norepinephrine

y = 0.3824x + 12.466

R2 = 0.8354

Norepinephrine

y = 1.1473x + 6.8051

R2 = 0.9264

Pre Nipride

y = 0.3471x + 12.689

R2 = 0.9056

Nipride

y = 0.3133x + 9.9684

R2 = 0.9297

Pre Dobutamine

y = 0.2118x + 15.883

R2 = 0.9073

Dobutamine

y = 0.4657x + 13.682

R2 = 0.9679

Page 6: AFP vs. EDM Baseline y = 1.1167x - 5.1519 R 2  = 0.9415 Pre Norepinephrine y = 0.7995x + 0.5933

Figure ESM 2d. Bland-Altman Analysis:

Conductance Catheter vs. PiCCODog 5/17- Baseline IVC Occlusion and Altered States

-15.00

-10.00

-5.00

0.00

5.00

10.00

15.00

0 5 10 15 20 25 30

(PiCCO+Conductance Catheter)/2

(PiC

CO

-Co

nd

uc

tan

ce

Ca

the

ter)

Baseline

Pre Norepinephrine

Norepinephrine

Pre Nipride

Nipride

Pre Dobutamine

Dobutamine

Page 7: AFP vs. EDM Baseline y = 1.1167x - 5.1519 R 2  = 0.9415 Pre Norepinephrine y = 0.7995x + 0.5933

Figure ESM 3a. ΔVolum eLV vs. Stroke DistanceAO: Conductance Catheter vs. Deltex EDM

Dog 6/04- Baseline IVC Occluison and Altered States

5.00

10.00

15.00

20.00

25.00

30.00

5.00 7.00 9.00 11.00 13.00 15.00 17.00 19.00 21.00 23.00

Conductance Catheter (ml)

De

lte

x E

DM

(c

m)

Baseline

Pre Norepinephrine

Norepinephrine

Pre Nipride

Nipride

Pre Dobutamine

Dobutamine

CC vs. EDM

Baseline

y = 0.3136x + 13.7

R2 = 0.9804

Pre Norepinephrine

y = 0.6394x + 8.6848

R2 = 0.5697

Norepinephrine

y = 0.6451x + 1.9371

R2 = 0.6878

Pre Nipride

y = 0.1766x + 9.1314

R2 = 0.9006

Nipride

y = 2.9286x - 7.983

R2 = 0.5909

Pre Dobutamine

y = 0.4666x + 19.52

R2 = 0.9016

Dobutamine

y = 0.596x + 6.1785

R2 = 0.9976

Page 8: AFP vs. EDM Baseline y = 1.1167x - 5.1519 R 2  = 0.9415 Pre Norepinephrine y = 0.7995x + 0.5933

Figure ESM 3b. Bland-Altman Analysis:

Conductance Catheter vs. Deltex EDMDog 6/04- Baseline IVC Occlusion and Altered States

-4.00

-2.00

0.00

2.00

4.00

6.00

8.00

10.00

12.00

14.00

5 7 9 11 13 15 17 19 21 23 25

(De ltex EDM +Conductance Cathe ter)/2

(De

lte

x E

DM

-Co

nd

uc

tan

ce

Ca

the

ter) Baseline

Pre Norepinephrine

Norepinephrine

Pre Nipride

Nipride

Pre Dobutamine

Dobutamine

Page 9: AFP vs. EDM Baseline y = 1.1167x - 5.1519 R 2  = 0.9415 Pre Norepinephrine y = 0.7995x + 0.5933

Figure ESM 3c. Conductance Catheter vs. PiCCO Dog 6/04- Baseline IVC Occlusion and Altered States

4.00

6.00

8.00

10.00

12.00

14.00

16.00

18.00

5.00 7.00 9.00 11.00 13.00 15.00 17.00 19.00 21.00 23.00

Conductance Catheter (ml)

PiC

CO

(m

l)

Baseline

Pre Norepinephrine

Norepinephrine

Pre Nipride

Nipride

Pre Dobutamine

Dobutamine

AFP vs. PCCO

Baseline

y = 0.1999x + 9.4397

R2 = 0.932

Pre Norepinephrine

y = 0.2162x + 8.2763

R2 = 0.4108

Norepinephrine

y = 1.1789x - 4.7965

R2 = 0.6238

Pre Nipride

y = 0.3074x + 4.526

R2 = 0.4597

Nipride

y = 0.5855x + 1.584

R2 = 0.6378

Pre Dobutamine

y = 0.3835x + 9.3934

R2 = 0.9707

Dobutamine

y = 0.5648x + 2.5527

R2 = 0.94

Page 10: AFP vs. EDM Baseline y = 1.1167x - 5.1519 R 2  = 0.9415 Pre Norepinephrine y = 0.7995x + 0.5933

Figure ESM 3d. Bland-Altman Analysis:

Conductance Catheter vs. PiCCODog 6/04- Baseline IVC Occlusion and Altered States

-8.00

-6.00

-4.00

-2.00

0.00

2.00

4.00

6.00

8.00

10.00

4 6 8 10 12 14 16 18 20

(PiCCO+Conductance Catheter)/2

(PiC

CO

-Co

nd

uc

tan

ce

Ca

the

ter)

Baseline

Pre Norepinephrine

Norepinephrine

Pre Nipride

Nipride

Pre Dobutamine

Dobutamine

Page 11: AFP vs. EDM Baseline y = 1.1167x - 5.1519 R 2  = 0.9415 Pre Norepinephrine y = 0.7995x + 0.5933

Figure ESM 4a. ΔVolumeAO vs. Stroke DistanceAO: Transonics Flow Probe vs. Deltex EDM

Dog 6/11- Baseline IVC Occlusion and Altered States

5.00

7.00

9.00

11.00

13.00

15.00

17.00

19.00

21.00

7.00 9.00 11.00 13.00 15.00 17.00 19.00

Transonics Flow Probe (ml)

De

lte

x E

DM

(c

m)

Baseline

Pre Norepinephrine

Norepinephrine

Pre Nipride

Nipride

Pre Dobutamine

Dobutamine

AFP vs. EDM

Baseline

y = 0.799x + 7.2887

R2 = 0.8412

Pre Norepinephrine

y = 1.0683x + 0.9032

R2 = 0.792

Norepinephrine

y = 0.7076x + 2.8312

R2 = 0.9928

Pre Nipride

y = 0.9884x + 1.3863

R2 = 0.9748

Nipride

y = 1.2168x + 1.2722

R2 = 0.9274

Pre Dobutamine

y = 0.182x + 11.74

R2 = 0.9809

Dobutamine

y = 1.2495x - 5.6067

R2 = 0.9601

Page 12: AFP vs. EDM Baseline y = 1.1167x - 5.1519 R 2  = 0.9415 Pre Norepinephrine y = 0.7995x + 0.5933

Figure ESM 4b. Bland-Altman Analysis:

Transonics Flow Probe vs. Deltex EDMDog 6/11- Baseline IVC Occlusion and Altered States

-4.00

-2.00

0.00

2.00

4.00

6.00

8.00

10.00

5 7 9 11 13 15 17 19 21 23 25

(De ltex EDM +Transonics Flow Probe)/2

(De

lte

x E

DM

-Tra

ns

on

ics

Flo

w P

rob

e)

Baseline

Pre Norepinephrine

Norepinephrine

Pre Nipride

Nipride

Pre Dobutamine

Dobutamine

Page 13: AFP vs. EDM Baseline y = 1.1167x - 5.1519 R 2  = 0.9415 Pre Norepinephrine y = 0.7995x + 0.5933

Figure ESM 4c. Transonics Flow Probe vs. PiCCO Dog 6/11- Baseline IVC Occlusion and Altered States

5.00

7.00

9.00

11.00

13.00

15.00

17.00

19.00

7.00 9.00 11.00 13.00 15.00 17.00 19.00 21.00

Transonics Flow Probe (ml)

PiC

CO

(m

l)

Baseline

Pre Norepinephrine

Norepinephrine

Pre Nipride

Nipride

Pre Dobutamine

Dobutamine

AFP vs. PCCO

Baseline

y = 0.6363x + 7.5808

R2 = 0.9692

Pre Norepinephrine

y = 0.4473x + 5.0976

R2 = 0.7301

Norepinephrine

y = 0.6459x + 3.8957

R2 = 0.9222

Pre Nipride

y = 0.4362x + 6.3943

R2 = 0.935

Nipride

y = 0.9042x - 1.2429

R2 = 0.9912

Pre Dobutamine

y = 0.3807x + 9.6242

R2 = 0.7499

Dobutamine

y = 0.3551x + 9.5883

R2 = 0.9192

Page 14: AFP vs. EDM Baseline y = 1.1167x - 5.1519 R 2  = 0.9415 Pre Norepinephrine y = 0.7995x + 0.5933

Figure ESM 4d. Bland-Altman Analysis:

Transonics Flow Probe vs. PiCCODog 6/11- Baseline IVCO and Altered States

-4.00

-2.00

0.00

2.00

4.00

6.00

8.00

10.00

5 7 9 11 13 15 17 19 21 23 25

(PiCCO+Transonics Flow Probe)/2

(PiC

CO

-Tra

ns

on

ics

Flo

w P

rob

e)

Baseline

Pre Norepinephrine

Norepinephrine

Pre Nipride

Nipride

Pre Dobutamine

Dobutamine

Page 15: AFP vs. EDM Baseline y = 1.1167x - 5.1519 R 2  = 0.9415 Pre Norepinephrine y = 0.7995x + 0.5933

Figure ESM 5a. ΔVolumeAO vs. Stroke DistanceAO: Transonics Flow Probe vs. Deltex EDM

Dog 6/12- Baseline IVC Occlusion and Altered States

10.00

15.00

20.00

25.00

30.00

35.00

5.00 7.00 9.00 11.00 13.00 15.00 17.00 19.00 21.00

Transonics Flow Probe (ml)

De

lte

x E

DM

(c

m)

Baseline

Pre Norepinephrine

Norepinephrine

Pre Nipride

Nipride

Pre Dobutamine

Dobutamine

AFP vs. EDM

Baseline

y = 0.6619x + 12.231

R2 = 0.9176

Pre Norepinephrine

y = 0.85x + 10.824

R2 = 0.7794

Norepinephrine

y = 0.8684x + 7.1179

R2 = 0.9859

Pre Nipride

y = 1.1964x + 5.2966

R2 = 0.952

Nipride

y = 1.4587x + 6.2218

R2 = 0.9666

Pre Dobutamine

y = 1.2691x + 5.5189

R2 = 0.9511

Dobutamine

y = 0.5272x + 13.531

R2 = 0.7984

Page 16: AFP vs. EDM Baseline y = 1.1167x - 5.1519 R 2  = 0.9415 Pre Norepinephrine y = 0.7995x + 0.5933

Figure ESM 5b. Bland-Altman Analysis:

Transonics Flow Probe vs. Deltex EDMDog 6/12- Baseline IVC Occlusion and Altered States

-1.00

1.00

3.00

5.00

7.00

9.00

11.00

13.00

15.00

10 12 14 16 18 20 22 24 26

(De ltex EDM +Transonics Flow Probe)/2

(De

lte

x E

DM

-Tra

ns

on

ics

Flo

w P

rob

e)

Baseline

Pre Norepinephrine

Norepinephrine

Pre Nipride

Nipride

Pre Dobutamine

Dobutamine

Page 17: AFP vs. EDM Baseline y = 1.1167x - 5.1519 R 2  = 0.9415 Pre Norepinephrine y = 0.7995x + 0.5933

Figure ESM 5c. Transonics Flow Probe vs. PiCCO Dog 6/12- Baseline IVC Occlusion and Altered States

5.00

10.00

15.00

20.00

25.00

30.00

35.00

5.00 7.00 9.00 11.00 13.00 15.00 17.00 19.00 21.00

Transonics Flow Probe (ml)

PiC

CO

(m

l)

Baseline

Pre Norepinephrine

Norepinephrine

Pre Nipride

Nipride

Pre Dobutamine

Dobutamine

AFP vs. PCCO

Baseline

y = 0.8308x + 7.3814

R2 = 0.9158

Pre Norepinephrine

y = 0.787x + 16.336

R2 = 0.923

Norepinephrine

y = 0.9483x + 2.1417

R2 = 0.9805

Pre Nipride

y = 1.0038x + 8.3511

R2 = 0.8997

Nipride

y = 0.5823x + 12.105

R2 = 0.9578

Pre Dobutamine

y = 0.5658x + 14.915

R2 = 0.9253

Dobutamine

y = 1.1214x + 11.908

R2 = 0.9697

Page 18: AFP vs. EDM Baseline y = 1.1167x - 5.1519 R 2  = 0.9415 Pre Norepinephrine y = 0.7995x + 0.5933

Figure ESM 5d. Bland-Altman Analysis:

Transonics Flow Probe vs. PiCCODog 6/12- Baseline IVC Occlusion and Altered States

-1.00

1.00

3.00

5.00

7.00

9.00

11.00

13.00

15.00

17.00

5 10 15 20 25 30

(PiCCO+Transonics Flow Probe)/2

(PiC

CO

-Tra

ns

on

ics

Flo

w P

rob

e)

Baseline

Pre Norepinephrine

Norepinephrine

Pre Nipride

Nipride

Pre Dobutamine

Dobutamine